Skip to content

Clinical trials

Phase 2 Parkinson Disease trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 2 Country / region: Portugal Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20081
20092
20162
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Products1
Bial - Portela C S.A.1
Bial R&D Investments, S.A.1
EMD Serono1
Genzyme, a Sanofi Company1
Juvantia Pharma Ltd1
Sanofi1
University Hospital, Lille1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease8
Basal Ganglia Diseases1
Central Nervous System Diseases1
Dyskinesias1
Hypotension, Orthostatic1
Movement Disorders1
Multiple System Atrophy1
Neurodegenerative Diseases1
Olivopontocerebellar Atrophies1
Parkinsonian Disorders1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.